Get the Stockscreener App
1.62
2.41%
-0.04
After Hours:
1.62
Neumora Therapeutics Inc stock is traded at $1.62, with a volume of 440.41K.
It is down -2.41% in the last 24 hours and up +8.00% over the past month.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
See More
Previous Close:
$1.66
Open:
$1.65
24h Volume:
440.41K
Relative Volume:
0.35
Market Cap:
$262.35M
Revenue:
-
Net Income/Loss:
$-274.18M
P/E Ratio:
-0.6392
EPS:
-2.5346
Net Cash Flow:
$-198.33M
1W Performance:
-3.57%
1M Performance:
+8.00%
6M Performance:
+17.39%
1Y Performance:
-86.31%
1-Day Range:
$1.615
$1.66
1-Week Range:
$1.615
$1.71
52-Week Range:
$0.611
$17.19
Neumora Therapeutics Inc Stock (NMRA) Company Profile
Name
Neumora Therapeutics Inc
Sector
Industry
Phone
(857) 760-0900
Address
260 ARSENAL PLACE, SUITE 1, WATERTOWN
Compare NMRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NMRA
Neumora Therapeutics Inc
|
1.62 | 263.97M | 0 | -274.18M | -198.33M | -2.5346 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Neumora Therapeutics Inc Stock (NMRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-02-25 | Downgrade | BofA Securities | Buy → Underperform |
| Mar-10-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Mar-07-25 | Downgrade | Guggenheim | Buy → Neutral |
| Mar-07-25 | Downgrade | Stifel | Buy → Hold |
| Jan-02-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-05-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-01-24 | Initiated | H.C. Wainwright | Buy |
| Jul-22-24 | Initiated | Needham | Buy |
| Jul-08-24 | Initiated | Mizuho | Outperform |
| Dec-12-23 | Initiated | Deutsche Bank | Hold |
| Oct-10-23 | Initiated | BofA Securities | Buy |
| Oct-10-23 | Initiated | Guggenheim | Buy |
| Oct-10-23 | Initiated | JP Morgan | Overweight |
| Oct-10-23 | Initiated | RBC Capital Mkts | Outperform |
| Oct-10-23 | Initiated | Stifel | Buy |
| Oct-10-23 | Initiated | William Blair | Outperform |
View All
Neumora Therapeutics Inc Stock (NMRA) Latest News
220,970 Shares in Neumora Therapeutics, Inc. $NMRA Acquired by Nuveen LLC - MarketBeat
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Sees Significant Drop in Short Interest - MarketBeat
Neumora Therapeutics, Inc. $NMRA Shares Purchased by Graham Capital Management L.P. - MarketBeat
Rate Hike: What’s the MACD signal for Neumora Therapeutics Inc.2025 Earnings Surprises & Low Risk Profit Maximizing Plans - classian.co.kr
How does Neumora Therapeutics Inc. perform in inflationary periodsJuly 2025 Trends & Technical Pattern Based Signals - 뉴스영
Neumora Therapeutics Inc. stock trend outlook and recovery pathMarket Growth Review & Low Drawdown Investment Ideas - Newser
What MACD signals say about Neumora Therapeutics Inc.Dividend Hike & Real-Time Stock Movement Alerts - Newser
Can momentum traders help lift Neumora Therapeutics Inc.Weekly Trading Summary & Verified Momentum Watchlists - Newser
Published on: 2025-09-06 04:28:35 - Newser
Can Neumora Therapeutics Inc. stock double in the next yearJuly 2025 WrapUp & Daily Profit Focused Screening - خودرو بانک
Will Neumora Therapeutics Inc. stock go up in YEARJuly 2025 Outlook & Free Fast Gain Swing Trade Alerts - خودرو بانک
Can Neumora Therapeutics Inc. outperform in the next rallyJuly 2025 Retail & Low Drawdown Momentum Ideas - خودرو بانک
What are Neumora Therapeutics Inc.’s earnings expectationsForecast Cut & High Yield Stock Recommendations - خودرو بانک
Can trapped investors hope for a rebound in Neumora Therapeutics Inc.Market Volume Summary & Real-Time Volume Triggers - Newser
What are the future prospects of Neumora Therapeutics Inc.July 2025 Market Mood & Growth Focused Entry Point Reports - خودرو بانک
Using RSI to spot recovery in Neumora Therapeutics Inc.2025 Trading Volume Trends & Fast Moving Market Watchlists - Newser
What machine learning models say about Neumora Therapeutics Inc.July 2025 Snapshot & AI Enhanced Market Trend Forecasts - Newser
Can swing trading help recover from Neumora Therapeutics Inc. lossesTrade Risk Assessment & Community Verified Trade Signals - Newser
What the charts say about Neumora Therapeutics Inc. today2025 Pullback Review & High Accuracy Trade Signal Alerts - Newser
Will a bounce in Neumora Therapeutics Inc. offer an exitGap Up & Fast Entry Momentum Trade Alerts - Newser
What is the long term forecast for Neumora Therapeutics Inc. stock - خودرو بانک
Published on: 2025-09-05 04:04:09 - خودرو بانک
Block Trades: Is now the right time to enter Neumora Therapeutics Inc.2025 Winners & Losers & Community Consensus Trade Signals - خودرو بانک
Published on: 2025-09-04 17:51:19 - خودرو بانک
Published on: 2025-09-04 05:04:03 - Newser
How to forecast Neumora Therapeutics Inc. trends using time series2025 Technical Overview & Free Weekly Watchlist of Top Performers - Newser
Momentum divergence signals in Neumora Therapeutics Inc. chartTrade Exit Summary & AI Forecast for Swing Trade Picks - Newser
What data driven models say about Neumora Therapeutics Inc.’s futureWeekly Trend Summary & Consistent Growth Equity Picks - Newser
Can Neumora Therapeutics Inc. sustain its profitabilityTrade Exit Summary & Daily Chart Pattern Signals - خودرو بانک
Has Neumora Therapeutics Inc. formed a bullish divergenceTrade Entry Report & High Accuracy Trade Alerts - Newser
Why Neumora Therapeutics Inc. is moving todayJuly 2025 Short Interest & AI Based Buy and Sell Signals - Newser
Can trapped investors hope for a rebound in Neumora Therapeutics Inc2025 Dividend Review & Fast Gaining Stock Strategy Reports - Newser
Custom watchlist performance reports with Neumora Therapeutics Inc.Quarterly Profit Review & Long-Term Capital Growth Strategies - Newser
Will Neumora Therapeutics Inc. benefit from sector rotationPortfolio Growth Summary & Risk Adjusted Swing Trade Ideas - خودرو بانک
Applying big data sentiment scoring on Neumora Therapeutics Inc.Dip Buying & Advanced Swing Trade Entry Alerts - Newser
Published on: 2025-09-03 02:32:48 - Newser
Published on: 2025-09-03 06:09:52 - خودرو بانک
Is now the right time to enter Neumora Therapeutics Inc.July 2025 Action & Long Hold Capital Preservation Tips - خودرو بانک
Neumora Therapeutics Inc. stock prediction for this weekJuly 2025 Rallies & Target Return Focused Stock Picks - Newser
Published on: 2025-09-03 06:19:09 - خودرو بانک
Can Neumora Therapeutics Inc. navigate macro headwindsQuarterly Profit Review & Free High Accuracy Swing Entry Alerts - خودرو بانک
Is Neumora Therapeutics Inc. a candidate for recovery playJuly 2025 Breakouts & Weekly Watchlist of Top Performers - Newser
Will Neumora Therapeutics Inc. benefit from geopolitical trendsSwing Trade & Low Risk Entry Point Guides - خودرو بانک
Reversal indicators forming on Neumora Therapeutics Inc. stock2025 Key Lessons & Free Real-Time Market Sentiment Alerts - Newser
Neumora Therapeutics Inc Stock (NMRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):